CLINICAL CASE
Riccardo was a 17-year-old natal male who described himself as "being a girl with boy parts," a proclamation that he verbalized at 15 years of age. She preferred to be referred to with female pronouns. She explained that these feelings manifested when she was very young, noting that she wanted to play Cinderella with friends and that her favorite toys were Barbie dolls and a pink stuffed animal. Even as a toddler, Riccardo always preferred to associate with female peers. Socially, Riccardo had transitioned to female gender. She had long bleached blonde hair and wore make-up, jewelry, and typical female clothing. Riccardo was delighted to "pass" as a female. However, she expressed distress about her masculine secondary sexual characteristics. She hated the broadening of her shoulders and development of facial and body hair and her Adam's apple. She explained that she felt that her genitalia did not "belong" to her. Riccardo said bluntly, "If hormones are not prescribed by a doctor, I will get them elsewhere."
At age 15, she was described as becoming increasingly defiant, withdrawn, angry, and depressed. On her 16th birthday, Riccardo requested to change her name to Racquel. Racquel was hospitalized for depression and prescribed antidepressants but reported that they had little benefit. Over the course of the following year, Raquel ingested high doses of over-the-counter medications and prescription drugs to "escape."
At the age of 17, under the care of a pediatric endocrinologist, Racquel began taking feminizing hormones, which she increased on her own to "speed up the process." Four months later, she died by suicide and left a note stating: "Nobody understands how hard it is to live in a body you don't belong in, and you're constantly persecuted for having a medical condition that wasn't under your control when all you're doing is trying to fix it and live life like everybody else."
If Racquel had received mental health support and hormonal therapy at a younger age, could her outcome have been different?
DEFINITION AND CLINICAL PRESENTATION
Sex, gender, and sexual orientation are independent constructs (Table 1) . Sex is a biological status, categorized as male, female, or intersex and indicated by factors that include chromosomes, gonads, internal reproductive organs, and external genitalia. Gender is a psychological status and denotes the attitudes, feelings, and behaviors associated with being male or female. Gender identity is the individual's articulation as to whether he or she is male, female, or transgender. Sex and gender identity overlap in most of the population, and when they do not, individuals may categorize themselves as transgender or transsexual. In contrast, the term cisgender indicates gender identity congruent with natal sex, and the term genderqueer denotes an absence of identification with either the male or female binary and instead an incorporation of sex-typical traits of both. Gender expression is the communication of gender-specific behaviors and attitudes, which vary in different cultural and social contexts; this expression may not be consistent with the individual's sex or gender identity. The terms gender variant and gender nonconforming are broad constructs used to identify individuals whose gender expression does not fit with their natal sex (but does not necessarily denote a transgender orientation). Sexual orientation is independent of gender identity (1) and is characterized by attraction to members of the opposite sex (heterosexual), attraction to members of one's own sex (gay or lesbian), and attraction to both sexes (bisexual). The diagnosis of gender identity disorder (GID) has been eliminated in the most recent Diagnostic and Statistical Manual of Mental Disorders (DSM-V), reflecting the evolving concept that transgender identity is not an independent pathology. However, feelings of discontent related to social stigmatization, isolation, and rejection in the context of the experience of a body or a natal sex-based assigned gender that are incongruent with gender identity may be defined by newer criteria as gender dysphoria (GD). (2) Table 2 lists the DSM-V diagnostic criteria for GD stratified by childhood or adolescence. The listed attitudes and behaviors must persist for at least 6 months and cause clinically significant impairment in function to meet the diagnosis.
ETIOLOGY AND EPIDEMIOLOGY
Gender identity is likely influenced by a combination of biology, socialization, and culture, (3) although specific and robust evidence is lacking. There is some support for a biological component to transgender identity. A twin study indicates a significant genetic component (62%) and a smaller nonshared environmental component for transgender identity. (4) Observations in humans with inborn disorders of excessive testosterone production and/or exposure show that direct effects of testosterone on the fetal brain are important for the development of male gender identity. (3) The number of individuals who identify as transgender appears to be increasing dramatically, suggesting possible environmental effects, (5) although the increase also could be a consequence of more widespread awareness and increased societal acceptance.
Prevalence studies related to gender identity are complicated and may be misleading for several reasons: (5) • The reported age at which individuals first identify themselves as transgender varies substantially • Gender identity may not be simply binary • Gender identity can be fluid for an individual across the lifespan Most young children whose gender expression is not congruent with their natal sex do not, in fact, ultimately assume transgender identities in adulthood. (6) The rate of persistence versus change (desistence) has been documented as approximately 16%. (7) However, experts are considering that previous studies may have underestimated long-term persistence. A key issue is that criteria for GID from earlier versions of the DSM on which the studies were based included diagnoses on the basis of transgender behavior alone. Some have suggested that the proportion of persisters would likely be higher by applying current GD criteria (rather than previous GID criteria) and, for example, including individuals who continued to express a desire to be of the opposite sex or to believe that they were the opposite sex, regardless of transgender behaviors per se. A second methodologic criticism is that most of the youth studied had not actually been followed into adulthood, suggesting that with longer follow-up, the number of apparent desisters might be lower. It seems clear, however, that most children whose gender-variant identity persists into adolescence develop an adult transgender identity. In these cases, puberty and attainment of secondary sexual characteristics is often a source of significant distress. (6) Prevalence estimates of transgenderism in adults in the United States vary from 0.005% to 0.014% for maleto-female (MTF) and 0.002% to 0.03% for female-to-male (FTM). In younger children, sex ratios of those referred to specialty clinics range from 2:1 to 4.5:1 for natal boys to girls; by adolescence, the natal sex ratio is close to equal. (2) Individuals who have GD have been reported in many cultures globally. Worldwide estimates range from 1:30,000 (0.003%) (6) for MTF to 6:100,000 (0.006%) to 1:33,800 (0.003%) for FTM. (7) MENTAL HEALTH AND SOCIAL COMORBIDITY Psychiatric comorbidity is very common in transgender youth, with depression, anxiety, and suicidality being two to three times more frequent than among cisgender controls. (8) In a recent large national transgender survey, a staggering 41% of adult respondents reported attempting suicide (compared to 1.6% of the general population), which serves as strong impetus for reexamining current treatment practices of GD in childhood. (9) Of great interest is a recent study that demonstrated that youth who were treated with pubertal suppression, cross-sex hormones, and gender reassignment surgery, in addition to being cared for by a highly trained multidisciplinary team that included mental health clinicians, had mental health outcomes similar to the general population. (10) Results of this study strongly suggested that many of the adverse psychological outcomes noted in transgender youth may be preventable with early recognition, hormonal treatment, and mental health support.
Youth who are validated in their transgender identity by their families and in their social environment have much better psychological outcomes. (11) Therefore, critical to their health is an investment in family counseling and education about gender identity and GD that can help parents to accept and support their children. This presents a challenge when parents have strong attitudes against accepting their child's transgender identity, which can be based on religious, cultural, or other strongly held philosophies. In such situations, the primary care clinician should continue education and refer the child for a mental health evaluation and/or counseling, considering the higher risk of depression, anxiety, and suicide.
Transgender children who have "come out" are more likely to be victimized by their peers. (12) How schools respond to these situations varies substantially, with many reports of teachers and administrative staff rejecting children's transgender status. Persistent use of the gendered birth name and nonpreferred pronouns is common practice in schools as well, which can be harmful to the transgender child. The school environment plays a major role in the psychosocial adjustment of transgender youth. Advocates who can help the family be aware, explain to them how to exercise their rights, and help educate school officials are now more widely available in the United States (Table 3) .
EVALUATION AND TREATMENT
The role of the primary clinician is to identify patients who may have GD, refer them to appropriate diagnostic and treatment centers, and provide anticipatory guidance and counseling. The primary clinician must actively seek out In both groups, these criteria must persist for at least 6 months and cause clinically significant impairment in function.
signs and symptoms of GD, which are often subtle and indirect, manifesting as mood or behavior changes. A parent or child may not express GD concerns directly for several reasons, including lack of awareness about this entity, shame, the belief and, in some cases, hope that GD-related behaviors will be transient or "a phase," and the belief that GD need not be addressed until adulthood. Identifying GD in patients who are peripubertal is especially important because the onset of puberty heightens the risk of depression, suicide, and selfdestructive choices and behaviors. (8)(13) Furthermore, in appropriate cases, this time can be the ideal juncture for initiating puberty-halting hormonal therapy.
The Prepubertal Child
The clinician who suspects GD in a prepubertal child may begin an initial assessment with direct, nonjudgmental questions such as, "Do you have any concerns that your child might have a problem with his or her gender?" An explicit differentiation between sexual attraction and gender identity should be offered to alleviate any potential ambiguity or misconception. The interview should be extended to investigate a description of and degree to which the child's mood and behavior are affected and whether there have been changes in the family and/or social dynamics or school performance. Information about gender nonconforming behaviors should be elicited (Table 4) , such as a preference for toys (eg, dolls for boys and trucks for girls) or clothing typical of the opposite sex (eg, boxer shorts instead of female underwear for girls), preoccupation with fantasy characters that are typically of greater interest to the opposite sex (such as the princess for natal boys), assumption of the role of the opposite-sex parent when engaged in pretend play, and preference for urination standing up for girls or sitting down for boys. Parents should be informed that the presence of one or two such behaviors, particularly when shortlived, does not predict an evolving transgender identity because gender nonconforming behaviors and preferences are frequently transient during childhood. However, tenacious expression of cross-sex interests, especially persistence of transgender identity into adolescence, suggests that the condition is not likely to revert thereafter. Mental health intervention may not be imperative; the decision likely will depend on the impact on the child, ie, if the child is gender nonconforming but does not appear to have psychological distress. On the other hand, if there is suspicion of GD with accompanying distress and/or if the family is challenged with adjusting to their child's identity, they should be referred to a mental health clinician promptly. Ideally, the mental health referral is to a clinician (psychologist, psychiatrist, or licensed therapist) with experience evaluating children with GD. Centers of expertise in this field with multidisciplinary programs are preferred, but in The mental health clinician should conduct an exhaustive and methodical evaluation for GD that assesses for psychological comorbidities and provide therapy as needed. "Reparative psychotherapy" aimed at changing the gender identity or expression and promoting acceptance of the natal sex has been shown to be both unsuccessful and psychologically deleterious. (15)(16)(17)(18) The "gender affirmative model" is more accepted among experts. This model defines gender health as a child's opportunity to live as the gender that feels most real or comfortable to that child and to express that gender with freedom from restriction, aspersion, or rejection. (19) Nevertheless, complete social gender transition in young children is controversial. Retrospectively, children whose GD persists beyond childhood will benefit most, but predicting whose transgender identity will persist is challenging and should only be determined with the help of a mental health therapist. (20) There is no recommended endocrine therapy or intervention for GD during prepubescence.
The Peripubertal and Pubertal Child or Adolescent
Identification of GD in patients who are peripubertal is especially important because puberty is associated with increased rates of high-risk behaviors and suicide. (8)(13) Furthermore, if endocrine therapy is deemed appropriate, this is the ideal time to intervene, ie, before the irreversible physical transformation caused by increasing concentrations of androgens and estrogens of puberty.
Adolescents are unlikely to broach the subject of GD with their physicians, and parents often have not identified the problem to that degree of specificity. Accordingly, the primary care clinician must have a high index of suspicion and persist in gathering pertinent history. Even if the parents are naïve to their child's GD, they often may express concerns about mood and behavior or have questions related to their child's sexual orientation. Education and engagement of family support is vital because the risk of suicide is heightened in the context of an unsupportive of family. The suicide attempt risk is 4% in a setting of strongly supportive parents and as high as 60% in those with nonsupportive parents. (21) When families fail to accept their child's gender of choice, the risk of homelessness, drug and alcohol abuse, prostitution, and use of illegally obtained hormones also is intensified. (13) Consistent with the standard for an adolescent psychosocial medical history interview, discussions about GD should initially take place with patient and caregivers separately. An example of a direct and nonjudgmental initial question for the adolescent can be, ''Do you think that you might have a problem with your gender?" The response may 
EXAMPLES OF GENDER NONCONFORMING BEHAVIOR AND PREFERENCES EXAMPLES OF SUGGESTED QUESTIONS AND PHRASING
Gender identity different from the sex assigned at birth Some young people feel that they were born in the wrong body; have you ever felt like that?
Persistence of gender identity different from the sex assigned at birth For how long have you felt that you were a girl/boy?
Gender Which character from the TV shows or movies do you admire?
Evaluation of source of distress What kinds of thoughts make you feel sad?
What do you think about your body?
*The purpose of obtaining a sensitive and thorough gender dysphoria-related history is not to diagnose gender dysphoria; rather, it is designed to assess the necessity for referral and further evaluation by a mental health clinician.
include content related to sexual attraction, gender identity, or both. Although most homosexual and bisexual adolescents do not have GD, a high percentage (50%-90%) of people with GD are homosexual in relation to their natal gender (but heterosexual in relation to their desired gender) or bisexual (10%). (22)(23)(24) If the patient appears to have GD, a prompt referral to a mental health clinician for diagnostic confirmation is recommended. According to data from adolescents who received support with mental health and/or endocrine therapy, GD that is present during adolescence persists in more than 90% of cases. (10)(25)(26) Prompt referral is of critical importance if puberty has begun because the patient might be eligible for pubertysuppressing endocrine therapy. Multidisciplinary centers, often based in pediatric endocrinology or adolescent medicine clinics, with collaborative mental health professionals are good resources. (14) The Endocrine Society, with the support of the Pediatric Endocrine Society, has provided guidelines for treatment of adolescents who meet strict eligibility criteria (Table 5) . (27) Of note, the criteria include that the patient must have initiated puberty based on physical examination, defined as Sexual Maturity Rating 2 for both males (genitalia) and females (breast development). Furthermore, any endocrine intervention must be performed in collaboration with a mental health professional.
Puberty suppression is achieved with gonadotropinreleasing hormone (GnRH) analogs, a therapy that has been used in children with precocious puberty since the 1980s. Such therapy allows a smoother social and physical transition to the gender role that is congruent with the child's gender identity. Suppressing puberty via a reversible process allows time for assessing the persistence of the affirmed gender as the child matures and before he or she undergoes irreversible physical changes from puberty. Furthermore, the therapy diminishes the psychological trauma and risk of suicide provoked by the physical changes of puberty. GnRH analogs are administered as intramuscular injections monthly or every 3 months (leuprolide acetate) or as a yearly subcutaneous implant (histrelin acetate). The suppressive reproductive axis effects of these therapies are reversible, and the adverse effect profiles are favorable and well characterized. Of note, GnRH analogs decrease growth velocity from a pubertal to a prepubertal rate. Subsequent treatment with cross-sex hormones appears to trigger "catch-up" growth and final height normalization, although research in this specific area is minimal. (28) Suppressive therapy with GnRH analogs for youth with GD has not been approved by the U.S. Food and Drug Administration. Financial coverage or reimbursement by insurance companies can be difficult to obtain, although this has improved substantially in recent years. Out-of-pocket expense can total 15,000 USD yearly.
Adolescents with GD who undergo pubertal suppression have improved behavioral, emotional, and depressive symptoms. (23)(26)(29) Adolescents with more advanced puberty (beyond Sexual Maturity Rating 2) may also be candidates for suppression of puberty to prevent the progression of later-onset secondary sexual characteristics, such as "masculine" facial bone structure, Adam's apple, facial hair, and a taller adult height in natal males. Moreover, this treatment may provide relief from the distress of menstrual periods in natal females and spontaneous erections in natal males. (27) The Endocrine Society recommends hormone replacement therapy (HRT), referred to as "cross-sex hormones," in adolescents age 16 years and older who fulfill the criteria outlined in Table 5 . (27) These include "feminizing hormones" for natal males such as estrogen and spironolactone (an androgen antagonist) and testosterone therapy for natal females. A GnRH analog is often continued to suppress endogenous testosterone or estrogen and allow for a lower dose of HRT. HRT has irreversible effects, such as breast and facial hair development with estrogen and testosterone, respectively. Greatly improved psychological well-being has been associated with HRT administration after timely suppression of puberty. (23)(26) When HRT is initiated after puberty (when cross-gender physical features have already developed), dissatisfaction with the affirmed gender appearance often persists, leading to further reparative surgeries and significant emotional distress.
Endocrine Society Guidelines (Table 5 ) recommend assessing comprehension of transgender outcomes and treatment risks even in minors, although this can be difficult to ascertain, particularly in younger patients. In practice, the depth of discussion depends on the age and maturity of the child. Nevertheless, endocrinologists should verify understanding of the parent(s) or legal guardian(s) involved, and many programs obtain written consent before initiating hormonal intervention.
The longest study of transgender adolescents who underwent a uniform protocol of pubertal suppression followed by HRT during adolescence and gender reassignment surgery in adulthood demonstrated that GD was alleviated in young adulthood (mean age 21 years). The psychosocial functioning improved and quality of life was similar or better than same-age adults from the general population. (10) Currently, gender reassignment surgery is not recommended before adulthood.
EDUCATION OF SUPPORT HEALTH STAFF
All individuals who have direct contact with patients, including nurses, medical assistants, reception desk staff, and others, should be educated about gender nonconformity and GD. Sensitivity training can have a profoundly positive impact on patients' experience in the clinical setting.
Parents and patients often report discrimination or, at the very least, feeling uncomfortable and sometimes are compelled to educate health staff about theirs or their child's gender identity. (30) CME quiz and references for this article are at http://pedsinreview. aappublications.org/content/37/3/89.
Summary
• The definition of gender dysphoria (GD) includes the experience of a body that is incongruent with gender identity. The prevalence of GD is not as yet known, but the current proposed numbers are likely underestimated. Prevalence studies are complicated by several confounding factors and results may be misleading. (5)(7) • On the basis of strong evidence from retrospective studies of relevant populations, clinicians should be especially vigilant in identifying GD in patients who are peripubertal because the onset of puberty heightens the risk of depression, anxiety, selfdestructive choices, and suicide. (8)(13) • On the basis of strong evidence, "reparative psychotherapy" is both unsuccessful and psychologically deleterious. (15)(16)(17) (18) On the basis of expert consensus, the "gender affirmative model" is more accepted. (19) • On the basis of strong evidence, adolescents treated with a protocol of pubertal suppression followed by hormone replacement therapy during adolescence and gender reassignment surgery in adulthood have improved psychological outcomes and quality of lives compared with age-matched adults from the general population. (10)(29)
• A large national transgender survey revealed that 41% of adult respondents had attempting suicide. On the basis of strong evidence, youth who are validated in their transgender identity by supportive family and social environments have much more favorable psychological outcomes. (11) The primary care clinician has a unique role and responsibility to identify patients with possible GD and provide anticipatory guidance, counseling, and family support. Primary health care clinicians can provide the impetus and means to greatly improve the lifelong psychological well-being of their patients with GD and potentially save lives. (9)(11)(13)(30)
Parent Resources from the AAP at HealthyChildren.org
• English only: https://www.healthychildren.org/English/ages-stages/gradeschool/Pages/Gender-Identity-and-Gender-Confusion-InChildren.aspx
